Our results showed a significant negative association between adiponectin and breast cancer in a cohort of healthy postmenopausal women at increased risk for breast cancer or postmenopausal women with resected DCIS of the breast, further supporting the role of adiponectin in breast cancer. This evidence concerns the gene ADIPOQ and breast carcinoma.